Clinical Trial Update: A Study to Learn About How Elinzanetant Works and How Safe it is in Women Having Sleep Disturbances Associated With Menopause [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and mechanism of elinzanetant in women with menopause-related sleep disturbances has completed and results are posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sleep Disturbances Associated with Menopause

Drugs mentioned

• Elinzanetant (elinzanetant)

Snippet

Sponsor: Bayer | Conditions: Sleep Disturbances Associated With Menopause | Phase 2 | Status: COMPLETED | Results posted: 2025-11-10